StimCell Energetics Inc. Stock
Stocks
STME
US15115X2062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3030 USD | -.--% |
|
+9.78% | -24.25% |
| Market Cap | 5.83M 5.13M 4.77M 4.38M 8.22M 563M 8.36M 56.67M 22.13M 276M 21.9M 21.43M 956M | P/E 2026 * |
-6.9x | P/E 2027 * | -13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.63M 5.84M 5.43M 4.98M 9.35M 641M 9.51M 64.44M 25.16M 314M 24.91M 24.37M 1.09B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
28.33% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | +9.78% | ||
| Current month | -3.50% | ||
| 1 month | -13.43% | ||
| 6 months | -34.13% | ||
| Current year | -24.25% |
| 1 month | 0.28 | 0.35 | |
| Current year | 0.28 | 0.48 | |
| 1 year | 0.25 | 0.48 | |
| 3 years | 0 | 13.97 | |
| 5 years | 0 | 13.97 | |
| 10 years | 0 | 25.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 56 | 2023-12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 48 | 2014-11-23 |
| Director | Title | Age | Since |
|---|---|---|---|
George Adams
CHM | Chairman | 78 | 2024-02-25 |
Joao da Costa
BRD | Director/Board Member | 62 | 2020-06-07 |
David Jeffs
BRD | Director/Board Member | 56 | 2023-12-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/18/25 | Sell | Director | 16,667 | 0.0807% | ||
| 3/17/25 | Tax | Director | 60,841,472 | 307.0278% | ||
| 2/25/25 | Buy | 15,000 | 0.0757% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +9.78% | +12.22% | +12.22% | 5.83M | ||
| +1.07% | -4.73% | -3.96% | +11.63% | 46.35B | ||
| +0.25% | +5.61% | +404.21% | +606.87% | 40.13B | ||
| -0.27% | +2.67% | +10.54% | +65.01% | 36.33B | ||
| +0.35% | -1.16% | +7.11% | -8.85% | 34.6B | ||
| +3.14% | +1.02% | +3.72% | +34.86% | 26.77B | ||
| +0.47% | -2.29% | - | - | 16.66B | ||
| -0.73% | +11.80% | +37.49% | +145.18% | 16.91B | ||
| +0.42% | -4.46% | +4.80% | +8.67% | 13.05B | ||
| -2.68% | -2.49% | -1.27% | -32.60% | 13.05B | ||
| Average | +0.20% | +0.91% | +52.76% | +93.67% | 24.38B | |
| Weighted average by Cap. | +0.46% | +0.77% | +76.79% | +132.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -792M -697M -648M -595M -1.12B -76.51B -1.14B -7.7B -3.01B -37.5B -2.97B -2.91B -130B | -510M -449M -417M -383M -719M -49.24B -731M -4.95B -1.93B -24.14B -1.91B -1.87B -83.53B |
| Net Debt | 800K 704K 654K 601K 1.13M 77.24M 1.15M 7.77M 3.03M 37.86M 3M 2.94M 131M | 800K 704K 654K 601K 1.13M 77.24M 1.15M 7.77M 3.03M 37.86M 3M 2.94M 131M |
Employees
1
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- STME Stock
Select your edition
All financial news and data tailored to specific country editions
















